Physicochemical and Phytochemical Evaluation of Psoralea corylifolia (Seed) and its Extract
DOI:
https://doi.org/10.18311/jnr/2024/36242Keywords:
Pharmacognostic Evaluation, Phytochemical Analysis, PsoriasisAbstract
Background: Herbal phytochemicals play an important role in the treatment of various dreadful diseases. Psoralea corylifolia is an annual herbaceous plant widely grown in India and other countries Secondary metabolites of P. corylifolia play a crucial role in various skin disorders like psoriasis, eczema and vitiligo as per literary and current reported studies. Various studies have indicated that the seeds of P. corylifolia possess antimicrobial and anti-inflammatory properties. Aim: To evaluate the physicochemical and phytochemical analysis of P. corylifolia. Methods: Psoralen, which is the main active chief constituent present in P. corylifolia, has great therapeutic potential for managing psoriasis. The utilisation of such constituents in Novel Drug Delivery System (NDDS) like micro-emulsions, nano-emulsions, phytosomes, etc. leads to enhanced therapeutic potential. But before proceeding, the formulation development quality control standardisation of every drug is a must for the effective performance of the drug. The standardisation of herbal drugs plays a crucial role in their enhanced therapeutic value. All the standardisation parameters of herbal drugs are widely available in various pharmacopoeias as well as in the Ayurvedic formulary. This article is an attempt to revalidate the physicochemical evaluations of P. corylifolia seeds along with the High-Performance Thin Layer Chromatography (HPTLC) profiling by using potent phytochemical markers. Results: The phytochemical investigation of the extract of P. corylifolia shows the presence of alkaloids, tannins, triterpenoids, glycosides, flavonoids etc. Conclusion: Based on findings, it is concluded that prepared extract can be utilised for further activities like formulation development where the extract can play an important role as compared to simple powder.
Downloads
Metrics
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Arun Kumar, Vikas Kumar Pal, Saurabh Singh, Shivani, Bimlesh Kumar, Dileep Singh Baghel, Kalvatala Sudhakar, Narendra Kumar Pandey, Kalpana Thakur, Sheetu Wadhwa, Aswin Viswanath, Amrik Singh, Avijit Mazumder, Gurmeet Singh (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Accepted 2024-06-25
Published 2024-08-31
References
Anonymous. The Ayurvedic Pharmacopoeia of India. Government of India Ministry of Health and Family Welfare Department of Ayush; 2008; 1(1):31.
Anonymous. The Ayurvedic Pharmacopoeia of India. Appendix-2. New Delhi. Government of India. Ministry of Health and Family Welfare. 2001; 1(3):207.
Anonymous. The Ayurvedic Pharmacopoeia of India, Government of India Ministry of Health and Family Welfare Department of Ayush. 2008; 1(1):31.
Available from: www.mdidea.com. [Available from 2022 Nov 11] 5. Jayalakshmi B, Shivarathana V, Madevamma HS, Amruthesh KN. Phytochemical, antibacterial and antioxidant studies on extracts of Psoralea corylifolia. Int J of Pharm and Biolog Sci. 2018; 200-5.
Behloul N, Wu G. Genistein: A promising therapeutic agent for obesity and diabetes treatment. Euro J of Pharma. 2013; 698(1):31-8. https://doi.org/10.1016/j.ejphar.2012.11.013 PMid:23178528.
Brands SJ, comp. (1989-2005), Systema Naturae, Amsterdam, The Netherlands, 2000. [www.taxonomicon.net] 8. Chopra RN, Chopra IC. Indigenous drugs of India. Kolkata. 1958. p. 2.
Gidwani B, Alaspure RN, Duragkar NJ, Singh V, Rao SP, Shukla SS. Evaluation of a novel herbal formulation in the treatment of eczema with Psoralea corylifolia. Iran J of Derm. 2010; 13:122-7.
Gidwani B, Alsapure RN, Duragkar NJ. Pharmacognostic and standardisation and physicochemical evaluation of Psoralea corylifolia Linn seeds. Imp J Pharmacog Nat Prod. 2011; 1(1):145-51.
Jeong D, Watari K, Shirouzu, T.Ono, M., Koizumi, K., Saiki, et al., Studies on lymphangiogenesis inhibitors from Korean and Japanese crude drugs. Biolog and Pharma bull. 2013; 36(1):152-7. https://doi.org/10.1248/bpb.b12-00871 PMid:23302649.
Maisch JM. Useful plants of the genus Psoralea. Amer. J of Pharm. 1889; (61):500-3.
Khurana D, Sharma S, Mir RS, Mohd A, Ajaz A, Muneeb RU, Parvaiz A, Mona AS, Mohamed ES, Mohd M. Extraction, quantification and cytokine inhibitory response of Bakuchiol in Psoralea corylifolia Linn. 2020; 7(3):487.
Khatune NA, Islam ME, Haque MF, Khondkar P, Rahman MM. Antibacterial compound from the seed of Psoralea corylifolia. Fito. 2004; 75(2):228-30. https://doi.org/10.1016/j.fitote.2003.12.018 PMid:15030932.
Khatune NA, Islam ME, Haque ME, Khondkar P, Rahman MM. Antibacterial compound from the seed of Psoralea corylifolia. Fito. 2004; 75(2):228-30. https://doi.org/10.1016/j.fitote.2003.12.018 PMid:15030932.
Khatune NA, Islam ME, Haque ME, Khondkar et al., editors. Antibacterial compounds from the seeds of Psoralea corylifolia. Fito. 2004; 75(2):228-30. https://doi.org/10.1016/j.fitote.2003.12.018 PMid:15030932.
Khatune NA, Islam ME, Haque ME, Khondkar P, Rahman MM. Antibacterial compounds from the seeds of Psoralea corylifolia. Fitoterapia. 2004; 75(2):228-30. https://doi.org/10.1016/j.fitote.2003.12.018 PMid:15030932.
Khushboo PS, Jadhav VM, Kadam VJ. Development and validation of a HPTLC method for determination of psoralen in Psoralea corylifolia (Bavachi). Int J of Pharm Tech Res. 2009; 1(4):1122-8. https://doi.org/10.4103/09737847.65331 PMid:22228944 PMCid: PMC3249905.
Kim DW, Seo KH, Curtis‐Long MJ, Oh KY et al. Phenolic phytochemical displaying SARS‐CoV papain‐like protease inhibition from the seeds of Psoralea corylifolia. J of Enz Inhib and Med Chem. 2014; 29(1):59-63. https://doi.org/10 .3109/14756366.2012.753591 PMid:23323951.
Kokate CK. Practical pharmacognosy. Delhi Vallabh Prakashan; 2003; 28-93 21. Kokate CK. Pharmacognosy. 47 Edition. Nirali Prakashan. 2012; 107.
Krishnamurthi AK, Manjunath BL, Sastri BN, Deshaprabhu SB, Chadha YR. The wealth of India: Raw materials, vol. VII. New Delhi: CSIR; 1969.
Krishnamurthy KV. Method in plant histochemistry. Madras: Vishwanadhan Pvt. Ltd. 1988; 1-77.
Nabi NG, Shrivastava M. Phytochemical screening and antioxidant activity of ethanol extract of P. corylifolia seeds. UK J Pharma and Biosci. 2017. 5(2); 2. https://doi.org/10.20510/ukjpb/5/i2/147015
Newton SM, Lau C, Gurcha SS, Besra GS, Wright CW. The evaluation of forty‐three plant species for antimycobacterial activities; Isolation of active constituent from Psoralea corylifolia and Sanguinaria canadensis. J of Ethn Pharm. 2012; 79(1):57-67. https://doi.org/10.1016/S03788741(01)00350-6 PMid:11744296.
Panda H. Herbs cultivation and medicinal uses. 2nd edition. New Delhi. National Institute of Industrial Research. 2000.
Patel PM, Patel NM, Goyal RK. Quality control of herbal products. The Ind Pharm. 2006; 5(45):26 30.
Patra KC, Pareta SK, Harwansh RK, Jayaram KK .Traditional approaches towards standardisation of herbal medicines - A review. J of Pharm Sci Technol. 2010; 2(11):372- 79.
Purkayastha S, Dahiya P. Phytochemical analysis and antibacterial efficacy of babchi oil (Psoralea corylifolia) against multi-drug resistant clinical isolates. International Conference on Bioscience, Biochemistry and Bioinformatics (IPCBEE), Singapore. IACSIT Press. 2012.
Makwana S, Mehere N, Bedarkar P, Biswajyoti P, Harisha CR. Comparative pharmacognosy and phytochemical evaluation of leaf, root, and stem of Psoralea corylifolia Linn. (Bakuchi). AYU. 2020; 41(4):235-41. https://doi.org/10.4103/ayu.ayu_79_21 PMid:35813361 PMCid: PMC9261993.
Sharma AK, Gaurav SS, Balkrishna A. A rapid and simple scheme for the standardization of polyherbal drugs. Int J of Green Pharm. 2009; 3:134-40. https://doi.org/10.4103/09738258.54904
Sharma PV. Dravyaguna Vijnan, Varanasi. 1986; 1(2).
Siva, G, Sivakumar S, Kumar GP, Vigneswaran M, Vinoth et al. Optimisation of elicitation condition with Jasmonic acid, characterisation and antimicrobial activity of Psoralen from direct regenerated plants of Psoralea corylifolia L. Biocat and Agri Biotech. 2015; 4(4):624-31. https://doi.org/10.1016/j.bcab.2015.10.012
Song K, Ling F, Huang A, Dong W, Liu G, Jiang C, et al. In vitro and in vivo assessment of the effect of antiprotozoal compounds isolated from Psoralea corylifolia against Ichthyophthirius multifiliis in fish. Int J for Parasito. Drugs and Drug Resi. 2015; 5(2):58-64. https://doi.org/10.1016/j.ijpddr.2015.04.001 PMid:26042195 PMCid: PMC4442694.
Straus SE. Herbal remedies. New Engl J Med. 2002; 47:2046-56. https://doi.org/10.1056/NEJMra020398 PMid:12490687.
Sun NJ, Woo SH, Cassady JM, Snapka RM. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J of Nat Prod. 2003; 66(5):734. https://doi.org/10.1021/np030135t
The wealth of India, raw materials, Volume. VIII. Council of Scientific and Industrial Research. New Delhi. 1969.
Singh S, Machawal L, Chauhan MG. Pharmacognostic study of male leaves of Trichosanthes dioica Roxb. with special emphasis on microscopic technique Journal of Pharmacognosy and Phytotherapy. 2010; 2(5):71-75.
Vaidya ADB, Devasagayam TPA. Current status of herbal drugs in India: An overview. J of Clin Biochem. 2007; 41(1):1-11. https://doi.org/10.3164/jcbn.2007001 PMid:18392106 PMCid: PMC2274994.
Won, T. H., Song, I.‐H, Kim, K.‐H, Yang, W.‐Y, Lee, S. K., Oh, D.‐C. Shin, J. Bioactive metabolites from the fruits of Psoralea corylifolia. J of Nat Prod. 2015, 78(4), 666-673. https://doi.org/10.1021/np500834d PMid:25710081
Won TH, Song IH, Kim KH, Yang WY, Lee SK, Oh DC, Shin J. Bioactive metabolites from the fruit of Psoralea corylifolia. J of Nat Prod. 2015, 78(4): 666-673. https://doi.org/10.1021/np500834d PMid:25710081
Won, T.H, Song I-H, Kim K-H, Yang, W-Y, Lee S K, Oh D-C, Shin J. Bioactive metabolites from the fruit of Psoralea corylifolia. J of Nat Prod. 2015, 78(4): 666-73. https://doi.org/10.1021/np500834d PMid:25710081.
Wong RW, Rabie ABM. Effect of psoralen on bone formation. J of Ortho Res. 2011; 29(2):158-64. https://doi.org/10.1002/jor.21124 PMid:20196083.
Zafar R, Panwar R, Sagar Bhanu PS. Herbal drug standardisation: The Ind Pharma. 2005; 4(36):21-5.